Digoxin immune fab
Bottle of digoxin immune fab | |
| Clinical data | |
|---|---|
| Trade names | Digibind, others |
| AHFS/Drugs.com | Consumer Drug Information |
| Routes of administration | IV infusion, injection |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Onset of action | 30 min |
| Elimination half-life | 15 hours for DigiFab, 23 hours for Digibind |
| Duration of action | 15 to 20 hrs |
| Excretion | Kidney |
| Identifiers | |
| |
| DrugBank | |
| ChemSpider |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C2085H3223N553O672S16 |
| Molar mass | 47301.88 g·mol−1 |
| (what is this?) (verify) | |
Digoxin immune fab or digoxin-specific antibody is an antidote for overdose of digoxin. It is made from immunoglobulin fragments from sheep that have already been immunized with a digoxin derivative, digoxindicarboxymethoxylamine (DDMA). Its brand names include Digibind (GlaxoSmithKline) and DigiFab (BTG plc).